(Q33392873)
Statements
Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer (English)
A D Seidman
A Brufsky
R H Ansari
L L Hart
R S Stein
L S Schwartzberg
J F Stewart
C A Russell
S-C Chen
L E Fein
S-B Kim
J Cavalheiro
L Zhao
J F Gill
C K Obasaju
M Orlando
17 November 2010